Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia

Virchows Archiv

Volumn 434, Issue 5, 1999, Pages 423-428

  Bamberger, Ana Maria ^a   Riethdorf, Lutz ^a   Milde Langosch, Karin ^a   Bamberger, Christoph M ^b   Thuneke, Imke ^b   Erdmann, Insa ^b   Schulte, Heinrich M ^b   Loning T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27; PROTEIN P53;

ARTICLE; CANCER GRADING; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIXED TUMOR, MESODERMAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033018797     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050361     Document Type: Article

References (33)

1. Bullrich F, MacLachlan TK, Sang N, Druck T, Veronese ML, Allen SL, Chiorazzi N, Koff A, Heubner K, Croce CM, Giordano A (1995) Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27/Kip1, to regions involved in human cancer. Cancer Res 55:1199-1205
2. Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM (1997) Decreased levels of the cell-cycle inhibitor p27/KIP1 protein: Prognostic implications in primary breast cancer. Nat Med 3:227-230
3. ink4. Mol Cell Biol 15:2682-2688
4. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253
5. Kip1-deficient mice. Cell 85:733-744
6. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ (1998) The murine gene p27/kip1 is haplo-insufficient for tumour suppression. Nature 396:177-180
7. Gillett C, Ranti V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817
8. Hung W-C, Chai C-Y, Huang J-S, Chuang L-Y (1996) Expression of cyclin D1 and c-ki-ras gene product in human epithelial ovarian tumors. Hum Pathol 27:1324-1328
9. Hunter T, Pines J (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582
10. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR, Koeffler HP (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55:2266-2269
11. Kip1. Cell 85:721-732
12. Koh J, Enders GH, Dynlacht BD, Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375:506-510
13. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependnet kinase inhibitor p27 in aggressive colorectal cancers. Nat Med 3:231-234
14. Milde-Langosch K, Ocon E, Becker G, Löning T (1998) p16/MTS1 inactivation in ovarian carcinomas: High frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer 79:61-65
15. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T (1997) p27 expression and gastric carcinoma. Nat Med 3:593
16. Morosetti R, Kawamata N, Gombart AF, Miller CW, Hatta Y, Hirama T, Said JW, Tomonaga M, Koeffler HP (1995) Alterations of the p27/KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86:1924-1930
17. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720
18. Nikaido T, Li S, Shiozawa T, Fujii S (1996) Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 78:1248-1253
19. Pagano M, Tam SW, Theodorras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
20. Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Voglestein B (1995) Assignment of the human p27/Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55:1206-1210
21. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
22. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59-66
23. Ponce-Castaneda MV, Lee M-H, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C (1995) p27/Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55:1211-1214
24. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27/KIP1 and cyclin E, alone or in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225
25. Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C, Peyrat JP (1995) Analysis of the p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 72:351-353
26. Riethdorf L, Begemenn C, Riethdorf S, Milde-Langosh K, Löning T (1996) Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis. Virchows Arch 428:47-51
27. Shapiro GI, Rollins BJ (1996) p16INK4 A as a human tumor suppressor. Biochim Biophys Acta 1242:165-169
28. Sherr CJ (1994) G1 phase progression: Cycling on cue. Cell 79:551-555
29. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
30. Sicinski P, Dohaner JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630
31. Steeg PS Abrams JS (1997) Cancer prognostics: Past present p27. Nat Med 3:152-154
32. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74
33. Yang R, Gombart AF, Serrano M, Koeffler HP (1995) Mutational effects on the p16INK4a tumor suppressor protein. Cancer Res 55:2503-2506